Search Market Research Report
Disposable Blood Bag Market Size, Share Global Analysis Report, 2022 – 2028
Disposable Blood Bag Market Size, Share, Growth Analysis Report By Collection Bags (Collection Bags and Transfer Bags), By End User (Blood Banks, Hospitals, and Non-Governmental Organizations (NGOs)), By Channel (Tender and Private Sales), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028
Industry Insights
[207+ Pages Report] According to Facts and Factors, the global disposable blood bag market size was worth USD 215.0 billion in 2021 and is estimated to grow to USD 283.47 billion by 2028, with a compound annual growth rate (CAGR) of approximately 4.70 percent over the forecast period. The report analyses the disposable blood bag market drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the disposable blood bag market.
Market Overview
Bio-medical equipment is a disposable blood bag that collects, stores, transports, and transfuses human blood and blood components. A needle cover and one or more tubes make up the system. These are produced using PVC that has been appropriately mixed with biocompatible additives. High-frequency welding creates the bags, which are then sterilized. Many lives have been saved thanks to the introduction of more harsh chemotherapy and bone marrow transplantation to treat leukemia and lymphoma patients, made possible by the availability of platelets for transfusion. The rise in blood transfusion operations, the rise in accidents and trauma cases, and the development of innovative disposable blood bag products by a significant number of key players all contribute to the growth of the global disposable blood bag market. The global disposable blood bag market is anticipated to grow due to rising rates of trauma & accidental injuries, tender-based purchases by governments of developing nations, customized blood bags with tracking systems provided by blood bag manufacturers, and simple accessibility of value-added products for blood collection. The global market for disposable plastic blood bags is anticipated to develop in future years. However, several drawbacks include inadequate blood collection and storage infrastructure and poor awareness of voluntary blood donation campaigns.
COVID-19 Impact:
The global market for disposable blood bags is expected to rise due to the COVID-19 epidemic. In the COVID-19 pandemic, passive immunotherapy using recovered patients' whole blood or plasma has emerged as a promising infection prevention method. Hospitals worldwide use the technique of transfusing neutralizing antibodies through recuperating blood. Blood bags have become more popular due to the quick uptake of immunotherapy using blood and plasma, which is anticipated to fuel market expansion for the forecasted period. As a result, the high risk connected to blood donation and transfusions restricts market expansion.
Key Insights
- As per the analysis shared by our research analyst, the global disposable blood bag market value is expected to grow at a CAGR of 4.70% over the forecast period.
- In terms of revenue, the global disposable blood bag market size was valued at around USD 215.20 million in 2021 and is projected to reach USD 283.47 million by 2028.
- The market for disposable blood bags is anticipated to expand as the prevalence of blood-related ailments and the demand for blood collection and transfer bags rise, coupled with the growing need for cost-effective solutions across the globe; e are the major factors driving the growth of the market.
- By collection bag, the collection bag category dominated the market in 2021.
- By end users, the hospital category dominated the market in 2021.
- North America dominated the global disposable blood bag market in 2021.
Growth Drivers
- The need for blood transfusion drives the market growth
The rise in blood-related diseases and the frequency of car accidents requiring blood transfusions are the main factors driving the growth of the worldwide disposable blood bag market. Blood transfusions are frequently used as supportive care in hematological therapy, major trauma, transplant surgery, and cardiovascular surgery.
Restraints
- The danger of transmission of diseases may hinder the market growth
When the plastic bags are utilized unevenly or contaminated, the risk of HIV transmission, hepatitis B or C transmission, and sepsis is enhanced. For instance, the most prevalent chronic bloodborne infection transmitted through blood transfusion is hepatitis C. These risks increase without a strong healthcare infrastructure for blood collection, storage, and delivery across numerous low-income nations. This is likely to restrict the global disposable bag market growth during the projection period.
Opportunity
- Ongoing development and research present market opportunities
During the forecast period, the market is anticipated to benefit from continuous research and development efforts by leading companies and universities to develop secure and sophisticated blood collection, transportation, and storage systems. For instance, Johns Hopkins University recently studied the use of drones to transport blood. It evaluates if shipping blood with drones is practical. These techniques offer an effective, secure, and rapid way to deliver blood supplies to small accidents, natural disasters, and other time-sensitive places. The market for disposable plastic blood bags is likely to benefit from this.
Segmentation Analysis
The disposable blood bag market is segregated based on collection bag, end user, channel, and region.
Based on collection bags, the market is divided into collection bags and transfer bags. Due to increased R&D activity in the pharmaceutical industry, growth in the number of product approvals, and a jump in the adoption of immunotherapy procedures, the collection bag segment dominated the market in 2021. Over the anticipated time frame, this tendency is expected to persist. The transfer bag market, however, is predicted to grow significantly throughout the forecast period due to an increase in surgeries.
Based on the end-user, the market is classified into blood banks, hospitals, and non-governmental organizations (NGOs). The hospital-based segment, which accounted for the largest share of end users in 2021, is anticipated to keep leading over the forecast period because of increased cardiac illnesses and trauma cases. However, because of an increase in transfusion operations, the stand-alone category is anticipated to develop significantly during the projection period.
Based on the channel, the market is classified into tender and private sales. By channel, the tender sales-based segment was the major contributor in 2021 and is expected to maintain its lead during the forecast period. Due to robust expansion strategies of blood bag makers through a tender process and high-profit margins, the tender sales channel segment is anticipated to account for the majority revenue share contribution to the worldwide disposable plastic blood bag market over the forecast period.
Recent Developments
- April 2021: For USD 55.2 million, Grifols purchased the seven U.S. plasma donation facilities from Kedrion. Grifols anticipates having immediate access to the plasma obtained at these facilities, which obtain about 240,000 liters annually due to the transaction.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 215.0 Billion |
Projected Market Size in 2028 |
USD 283.47 Billion |
CAGR Growth Rate |
4.70% |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Fresenius SE & Co. KGaA, Terumo Corporation, Grifols S.A., HLL Lifecare Limited, Poly Medicure Limited, MacoPharma S.A., INNVOL Medical India Limited, Span Healthcare Private Limited., and Others |
Key Segment |
By Collection Bags ,End User, Channel, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Landscape
- North America dominated the disposable blood bag market in 2021
Due to the presence of major players, the expansion of the healthcare industry, and the introduction of new disposable blood bag products in the region, North America accounted for the largest share of the global disposable blood bag market in 2021 and is predicted to maintain its dominance throughout the forecast period. Furthermore, the region's industry will soon be boosted by reputable health care companies, government initiatives to encourage the use of disposable blood bags, and ever-improving sterility standards. The rising incidence of trauma & accidents and the increased frequency of blood transportation & transfusion procedures are major market drivers for disposable blood bags.
Competitive Landscape
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Grifols S.A.
- HLL Lifecare Limited
- Poly Medicure Limited
- MacoPharma S.A.
- INNVOL Medical India Limited
- Span Healthcare Private Limited.
Global Disposable Blood Bag Market is segmented as follows:
By Collection Bags
- Collection Bags
- Transfer Bags
By End User
- Blood Banks
- Hospitals
- Non-governmental Organizations (NGOs)
By Channel
- Tender Sales
- Private Sales
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Grifols S.A.
- HLL Lifecare Limited
- Poly Medicure Limited
- MacoPharma S.A.
- INNVOL Medical India Limited
- Span Healthcare Private Limited.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors